Gadolinium encephalopathy in a patient with renal failure

Neurology. 2005 Apr 12;64(7):1276-8. doi: 10.1212/01.WNL.0000156805.45547.6E.

Abstract

Gadolinium chelates are extensively used in MRI studies. Neurotoxicity due to gadolinium chelates is minimal and uncommon. A 57-year-old woman in renal failure developed a subacute encephalopathy after inadvertent repetitive gadolinium contrast administration. An unusual MRI appearance with CSF hyperintensity due to gadolinium diffusion into the CSF is also shown.

Publication types

  • Case Reports

MeSH terms

  • Amnesia, Retrograde / etiology
  • Brain / drug effects*
  • Brain / metabolism
  • Brain / pathology
  • Brain Diseases, Metabolic / cerebrospinal fluid
  • Brain Diseases, Metabolic / chemically induced*
  • Brain Diseases, Metabolic / physiopathology
  • Causality
  • Cerebrospinal Fluid / chemistry
  • Cerebrospinal Fluid / drug effects
  • Consciousness Disorders / cerebrospinal fluid
  • Consciousness Disorders / chemically induced
  • Consciousness Disorders / physiopathology
  • Female
  • Gadolinium / pharmacokinetics
  • Gadolinium / poisoning*
  • Humans
  • Hypertension / complications*
  • Hypertension / diagnosis
  • Hypertension / physiopathology
  • Magnetic Resonance Imaging
  • Metabolic Clearance Rate / physiology
  • Middle Aged
  • Patient Selection
  • Recovery of Function
  • Renal Insufficiency / complications*
  • Renal Insufficiency / metabolism
  • Renal Insufficiency / physiopathology

Substances

  • Gadolinium